What’s New

Home What’s New

13

Nov2023

PMPRB Invites Stakeholder Feedback on Scoping Paper on Themes for New Guidelines

On November 10, 2023, the Patented Medicine Prices Review Board (PMPRB) launched first phase of its consultation process ... Read More

02

Oct2023

PMPRB Publishes Final Decision on Amended Interim Guidance

On September 27, 2023, the Patented Medicine Prices Review Board (PMPRB) published its final decision regarding the Amended ... Read More

08

Sep2023

PDCI Strengthens Leadership to Enhance Real World Evidence (RWE) Services and Strategic Consulting Capabilities

Mississauga, ON - September 11, 2023 – Canada’s leading biopharmaceutical pricing and reimbursement consultancy, PDCI Market Access (PDCI), ... Read More

05

Sep2023

pCPA Appoints Douglas Clark as its First CEO

On September 5, 2023, the pan-Canadian Pharmaceutical Alliance (pCPA) announced the appointment of Douglas Clark as its first ... Read More